|
Cyto10C9 |
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
2-(butylamino)quinolin-8-ol |
Depiction based on curated SMILES
H
3
C
NH
N
OH
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun; Smith MA, et al. 2012. Chem Biol |
|
2-cyano-N'-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)ethanimidamide |
Depiction based on curated SMILES
S
N
N
N
H
2
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
2-methoxyacridin-9-amine |
Depiction based on curated SMILES
N
NH
2
CH
3
O
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
4,6-dimethyl-N-[(Z)-1-pyridin-2-ylethylideneamino]pyrimidin-2-amine |
Depiction based on curated SMILES
CH
3
N
CH
3
CH
3
N
HN
N
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
5,7-diiodo-1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-8-ol |
Depiction based on curated SMILES
OH
I
I
N
H
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
5,7-dinitroquinolin-8-ol |
Depiction based on curated SMILES
_
O
N
OH
O
O
+
N
_
O
+
N
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
Diethyl 6-bromo-2,4-quinolinedicarboxylate |
Depiction based on curated SMILES
H
3
C
O
O
Br
CH
3
N
O
O
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
2-(4-tert-Butyl-phenoxymethyl)-4-hydroxy-pyrimidine-5-carboxylic acid ethyl ester |
Depiction based on curated SMILES
CH
3
H
3
C
H
3
C
O
CH
3
O
HN
N
O
O
|
Brucella |
VirB type IV secretion system |
Preclinical (in vivo) |
Paschos A, et al. 2011. Infect Immun |
|
| | |
| | |
| | |